Modulation of experimental myasthenia gravis by IVIg;Modulation de la myasthenie experimentale par les IgIV

Annales de Medecine Interne

Volumn 151, Issue SUPPL. 1, 2000, Pages

  Berrih Aknin, Sonia ^a,c   Aissaoui, Abderrahim ^a   Yamamoto, Maria ^b   Kaveri, Srinivas V ^d  

^a EUROPEAN SPACE AGENCY   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d NONE

Author keywords

Acetylcholine receptor; IVIg; Myasthenia Gravis; SCID mice; Thymus

Indexed keywords

ANTIBODY; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ACETYLCHOLINE; AUTOANTIBODY; IMMUNOGLOBULIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; CONTROLLED STUDY; IMMUNOMODULATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; REVIEW; ACUTE DISEASE; ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SKELETAL MUSCLE;

ACETYLCHOLINE; ACUTE DISEASE; ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MICE; MICE, SCID; MUSCLE, SKELETAL; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHOLINERGIC;

EID: 0034180464     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. VINCENT A, NEWSOM-DAVIS J: Acetylcholine receptor antibody as a diagnosis test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry, 1985; 48: 1246-52.
2. GENKINS S, PAPATESTAS AE, HOROWITZ SH, KORNFELD P: Studies in myasthenia gravis: early thymectomy. Am J Med, 1975; 58: 517-24.
3. BEGHI E, ANTOZZI C, BATOCCHI AP, et al.: Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci, 1991; 106; 213-20.
4. BERRIH-AKNIN S, MOREL E, RAIMOND F, et al.: The role of the thymus in myasthenia gravis: immuno-histological and immunological studies in 115 cases. Ann N Y Acad Sci, 1987; 505: 50-70.
5. BERRIH S, MOREL E, GAUD C, Raimond E, LE BRIGAND H, BACH J F: Anti-AChR antibodies, thymic histology and T cell subsets in myasthenia gravis. Neurology, 1984; 34: 66-71.
6. MARTINO G, DUPONT BL, WOLLMANN R, et al.: The human-severe combined immunodeficiency myasthenic mouse model: A new approach forthe study of myasthenia gravis. Ann Neurol, 1993; 34: 48-56.
7. SCHÖNBECK S, PADBERG F, HOHLFELD R, et al.: Transplantation of thymic autoimmune microenvironment to severe combined immunodeficient mice. A new model of myasthenia gravis. J Clin Invest, 1992; 90: 245-50.
8. AISSAOUI A, KLINGEL-SCHMITT II , COUDERC J, D et al.: Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol, 1999; 46: 559-67.
9. DWYER JM: Manipulating the immune system with immune globulin. N Engl J Med, 1992; 326: 107-16.
10. KAZATCHKINE MD, DIETRICH G, HUREZ V, et al. V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg). Immunol Rev, 1994; 139: 79-107.
11. GAJDOS P, CHEVRET S, CLAIR B, et al.: Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol, 1997; 41: 789-96.
12. JONGEN JL, VAN-DOORN PA, VAN-DER-MECHE FG; High-dose intravenous immunoglobulin therapy for myasthenia gravis. J Neurol, 1998; 245: 26-31.
13. HERRMANN DN, CARNEY PR, WALD JJ; Juvenile myasthenia gravis: treatment with immune globulin and thymectomy. Pediatr Neurol, 1998; 18: 63-6.
14. LIBLAU R, GAJDOS P, BUSTARRET FA, et al.: Intravenous gammaglobulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies. J Clin Immunol, 1991; 11: 128-31.
15. HUREZ V, KAZATCHKINE MD, RAMANATHAN S, et al.: Pooled normal human polyspecific IgM contains neutralyzing antiidiotypes to IgG autoantibodies of autoimmune patients and protects from autoimmune disease. Blood, 1997; 70: 4004-13.
16. VASSILEV T, YAMAMOTO M, AISSAOUI A, et al.: Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol, 1999; 29: 2436-42.
17. ROSSI F, KAZATCHKINE MD: Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol, 1989; 143: 4104-9.
18. ROSSI F, DIETRICH G, KAZATCHKINE MD: Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev, 1989; 110: 135-49.
19. YU Z, LENNON VA: Mechanisms os intravenous immune globulins therapy in antibody-mediated autoimmune diseases. N Engl J Med, 1999; 340: 227-8.
20. ADIB M, RAGIMBEAU J, AVRAMEAS S, et al.: IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol, 1990; 145: 3807-13.
21. MOUTHON L, NOBREGA A, NICOLAS N, et al.: Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci USA, 1995; 92: 3839-43.